35.50 USD
▲+2.06+6.16%
盘后 35.82 +0.90%
2026-09-15
市值
$1.08B
市盈率
—
EPS
-0.65
股息率
—
52 周区间
17.72 – 44.28
成交量
519.84K
Beta
0.99
目标价
44.00
52W 低 17.7252W 高 44.28
价格走势
公司简介
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasi...